$8.07
0.50%
Nasdaq, Oct 02, 03:59 pm EDT. Closed.
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Target price 2026 - Analyst rating & recommendation

SOPHiA Genetics SA Classifications & Recommendation

Buy
91%
Hold
9%

SOPHiA Genetics SA Price Target

Target Price $9.18
Price $8.07
Potential
Number of Estimates 6
6 Analysts have issued a price target SOPHiA Genetics SA 2027 . The average SOPHiA Genetics SA target price is $9.18. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 10 Analysts recommend SOPHiA Genetics SA to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the SOPHiA Genetics SA stock has an average upside potential 2027 of . Most analysts recommend the SOPHiA Genetics SA stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 77.27 97.16
18.57% 25.74%
EBITDA Margin -75.13% -32.38%
15.54% 56.90%
Net Margin -102.24% -80.08%
6.62% 21.67%

7 Analysts have issued a sales forecast SOPHiA Genetics SA 2026 . The average SOPHiA Genetics SA sales estimate is

$97.2m
unlock
. This is
12.75% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$100m 16.62%
unlock
, the lowest is
$93.2m 8.11%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $77.3m 18.57%
2026
$97.2m 25.74%
unlock
2027
$120m 23.76%
unlock
2028
$157m 30.86%
unlock
2029
$177m 12.73%
unlock
2030
$242m 36.17%
unlock

6 Analysts have issued an SOPHiA Genetics SA EBITDA forecast 2026. The average SOPHiA Genetics SA EBITDA estimate is

$-31.5m
unlock
. This is
45.53% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-30.7m 46.92%
unlock
, the lowest is
$-31.3m 45.81%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-58.1m 0.14%
2026
$-31.5m 45.80%
unlock
2027
$-22.6m 28.29%
unlock
2028
$-5.6m 75.17%
unlock
2029
$14.3m 354.85%
unlock
2030
$63.5m 345.00%
unlock

EBITDA Margin

2025 -75.13% 15.54%
2026
-32.38% 56.90%
unlock
2027
-18.76% 42.06%
unlock
2028
-3.56% 81.02%
unlock
2029
8.05% 326.12%
unlock
2030
26.31% 226.83%
unlock

7 SOPHiA Genetics SA Analysts have issued a net profit forecast 2026. The average SOPHiA Genetics SA net profit estimate is

$-77.8m
unlock
. This is
3.81% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-68.8m 14.90%
unlock
, the lowest is
$-80.9m 0.05%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-79.0m 26.42%
2026
$-77.8m 1.52%
unlock
2027
$-52.6m 32.37%
unlock
2028
$-26.9m 48.84%
unlock

Net Margin

2025 -102.24% 6.62%
2026
-80.08% 21.67%
unlock
2027
-43.76% 45.35%
unlock
2028
-17.11% 60.90%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.17 -0.91
23.16% 22.22%
P/E negative
EV/Sales 6.60

7 Analysts have issued a SOPHiA Genetics SA forecast for earnings per share. The average SOPHiA Genetics SA EPS is

$-0.91
unlock
. This is
16.51% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.81 25.69%
unlock
, the lowest is
$-0.95 12.84%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.17 23.16%
2026
$-0.91 22.22%
unlock
2027
$-0.62 31.87%
unlock
2028
$-0.32 48.39%
unlock

P/E ratio

Current -7.40 97.20%
2026
-8.83 19.26%
unlock
2027
-13.06 47.90%
unlock
2028
-25.52 95.41%
unlock

Based on analysts' sales estimates for 2026, the SOPHiA Genetics SA stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.44
2026
6.60 11.30%
unlock
2027
5.33 19.20%
unlock
2028
4.07 23.59%
unlock
2029
3.61 11.29%
unlock
2030
2.65 26.56%
unlock

P/S ratio

Current 7.97 99.07%
2026
7.07 11.31%
unlock
2027
5.71 19.20%
unlock
2028
4.37 23.58%
unlock
2029
3.87 11.29%
unlock
2030
2.84 26.56%
unlock

Current SOPHiA Genetics SA Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG
Locked
➜
Locked
Locked Aug 05 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Aug 05 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jul 20 2026
BTIG
Locked
➜
Locked
Locked Jun 15 2026
BTIG
Locked
➜
Locked
Locked May 06 2026
BTIG
Locked
➜
Locked
Locked Apr 15 2026
Guggenheim
Locked
➜
Locked
Locked Jan 26 2026
Analyst Rating Date
Locked
BTIG:
Locked
➜
Locked
Aug 05 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Aug 05 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jul 20 2026
Locked
BTIG:
Locked
➜
Locked
Jun 15 2026
Locked
BTIG:
Locked
➜
Locked
May 06 2026
Locked
BTIG:
Locked
➜
Locked
Apr 15 2026
Locked
Guggenheim:
Locked
➜
Locked
Jan 26 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today